ClinicalTrials.Veeva

Menu

Dipole Density Mapping of Right and Left Atrial Supraventricular Tachycardia (DDRAMATIC-SVT)

A

Acutus Medical

Status

Withdrawn

Conditions

Supraventricular Tachycardia

Treatments

Device: Mapping with the Acutus Medical System followed by Ablation

Study type

Interventional

Funder types

Industry

Identifiers

NCT01914575
CL-SVT-003

Details and patient eligibility

About

Use of dipole density mapping to identify activation in complex supraventricular tachycardias

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. aged 18 to 75 years
  2. scheduled for ablation of atypical atrial flutter or paroxysmal atrial fibrillation
  3. able and willing to give informed consent

Exclusion criteria

  1. implanted prosthetic, artificial, or repaired cardiac valves in the chamber being mapped, permanent pacemaker or ICD leads in the chamber being mapped, and/or hypercoagulopathy or an inability to tolerate anticoagulation .
  2. myocardial infarction within the prior two months
  3. cardiac surgery within the prior three months
  4. intracardiac thrombus
  5. clinically significant tricuspid valve regurgitation or stenosis
  6. any cerebral ischemic event in the prior six months
  7. pregnant or nursing
  8. currently enrolled in any other clinical investigation

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 1 patient group

Dipole Density Mapping
Experimental group
Treatment:
Device: Mapping with the Acutus Medical System followed by Ablation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems